We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
101
Thermo Fisher Scientific
TMO
$220B
$4.02M 0.13%
6,969
+748
+12% +$422K
KDP icon
102
Keurig Dr Pepper
KDP
$40.8B
$3.96M 0.13%
112,228
+82,136
+273% +$2.89M
XLK icon
103
State Street Technology Select Sector SPDR ETF
XLK
$124B
$3.94M 0.13%
52,186
+50,814
+3,704% +$3.5M
PAYX icon
104
Paychex
PAYX
$42.7B
$3.93M 0.13%
34,329
+23,858
+228% +$2.71M
GSLC icon
105
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
$15.5B
$3.9M 0.12%
47,966
+26,102
+119% +$2.07M
LMT icon
106
Lockheed Martin
LMT
$136B
$3.89M 0.12%
8,220
+2,723
+50% +$1.28M
PLD icon
107
Prologis
PLD
$133B
$3.87M 0.12%
31,012
+4,656
+18% +$572K
DHI icon
108
D.R. Horton
DHI
$42.3B
$3.8M 0.12%
38,870
+32,400
+501% +$3.09M
SDY icon
109
State Street SPDR S&P Dividend ETF
SDY
$23.9B
$3.79M 0.12%
30,612
+6,300
+26% +$793K
PFE icon
110
Pfizer
PFE
$153B
$3.79M 0.12%
92,785
-557
-0.6% -$24.1K
SDS icon
111
ProShares UltraShort S&P500
SDS
$390M
$3.75M 0.12%
18,762
+7,248
+63% +$1.54M
ITA icon
112
iShares US Aerospace & Defense ETF
ITA
$14.7B
$3.74M 0.12%
32,497
+437
+1% +$49.7K
FCNCA icon
113
First Citizens BancShares
FCNCA
$25.3B
$3.66M 0.12%
3,764
+3,104
+470% +$2.31M
AMT icon
114
American Tower
AMT
$80.4B
$3.65M 0.12%
17,872
+3,019
+20% +$633K
VBK icon
115
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.5B
$3.6M 0.11%
16,661
+12,887
+341% +$2.79M
UPRO icon
116
ProShares UltraPro S&P 500
UPRO
$5.7B
$3.57M 0.11%
92,549
+35,141
+61% +$1.28M
FXZ icon
117
First Trust Materials AlphaDEX Fund
FXZ
$398M
$3.51M 0.11%
53,750
+25,308
+89% +$1.7M
SVXY icon
118
ProShares Short VIX Short-Term Futures ETF
SVXY
$206M
$3.47M 0.11%
108,930
-246,810
-69% -$7.77M
SCHX icon
119
Schwab US Large- Cap ETF
SCHX
$74.5B
$3.45M 0.11%
214,014
+213,159
+24,931% +$3.35M
IYE icon
120
iShares US Energy ETF
IYE
$1.71B
$3.4M 0.11%
77,724
+45,917
+144% +$2.08M
IEO icon
121
iShares US Oil & Gas Exploration & Production ETF
IEO
$543M
$3.39M 0.11%
39,508
+39,041
+8,360% +$3.5M
CSGP icon
122
CoStar Group
CSGP
$12.3B
$3.33M 0.11%
48,323
+30,377
+169% +$2.24M
PYPL icon
123
PayPal
PYPL
$50.5B
$3.31M 0.11%
43,520
-28,809
-40% -$2.22M
XLV icon
124
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$3.29M 0.1%
25,410
-7,757
-23% -$1.01M
CMCSA icon
125
Comcast
CMCSA
$90B
$3.23M 0.1%
85,234
-28,500
-25% -$1.08M

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.